Retrospective analysis of the provision of urological care to patients with chronic balanoposthitis against the background of carbohydrate metabolism disorders

The study purpose. To conduct a retrospective analysis of the results of providing urological care to patients with chronic balanoposthitis on the background of carbohydrate metabolism disorders..

Patients and methods. A retrospective analysis of the results of treatment of phimosis due to chronic balanoposthitis in 95 patients was carried out. All patients were divided into two groups. The 1st group included men who showed signs of impaired carbohydrate metabolism (n = 41; 43.1 %). The 2nd group consisted of patients who had no metabolic disorders (n = 54; 56.9 %). The average age of 41 men of the first group was 48.2 ± 17.5 years, the second group of 54 men – 44.6 ± 15.3 years (p > 0.05). According to the indications, all patients underwent local therapy with antiseptics and antimicrobial drugs. In the presence of frequent relapses of balanoposthitis, persistent pain syndrome, the presence of phimosis according to the indications, circumcision of the foreskin was performed. In all patients, the time of surgery, the volume of blood loss during circumcision, and the duration of wound healing were evaluated. We considered the clinical case completed after complete regeneration of the wound.

Results. Conservative therapy of balanoposthitis in patients without impaired carbohydrate metabolism was effective in 85.1 %, and in men with type 2 diabetes mellitus (DM2) only in 9.7 %. Consequently, hyperglycemia reduces the effectiveness of conservative therapy of this disease by eight times. In patients with DM2, circumcision was performed 4.6 times more often than in the control group. The correlation of signs of hyperglycemia and the need for surgical treatment of balanoposthitis was 0.66. The duration of circumcision in group 1 was longer by 7.3 ± 3.6 min. compared with the second group (p < 0.05). Wound healing in patients with DM2 was observed almost twice as long (p < 0.05). Thus, with DM2, balanoposthitis is more difficult to treat. If balanoposthitis has a recurrent course, then circumcision can be considered as the final treatment option.

Conclusion. Balanoposthitis in patients with impaired carbohydrate metabolism often has a chronic form. In patients with DM2, conservative therapy of inflammation of the foreskin of the penis is effective in one out of ten cases. In adult men, balanoposthitis was more common in middle and old age. Among patients of this age, 11 (26.8 %) people had hyperglycemia for the first time. Consequently, men of the above age may be at risk and need more careful examination of the external genitalia and control of the level of glycemia.

1. Borelli S, Lautenschlager S. Differenzialdiagnose und Management der Balanitis [Differential diagnosis and management of balanitis]. Hautarzt. 2015 Jan;66(1):6–11. German. https://doi.org/10.1007/s00105-014-3554-0

2. Morris BJ, Wamai RG, Henebeng EB, Tobian AA, Klausner JD, Banerjee J, Hankins CA. Estimation of country-specific and global prevalence of male circumcision. Popul Health Metr. 2016 Mar 1;14:4. https://doi.org/10.1186/s12963-016-0073-5. Erratum in: Popul Health Metr. 2016;14:11

3. Smernitsky AM, Krasnyak SS, Shaderkina VA, Voevodina AK. Balanoposthitis in clinical practice: evaluation of the effectiveness of the Balanex complex. Experimental and Clinical Urology. 2022;15(2)140–146. (In Russ.). https://doi.org/10.29188/2222-8543-2022-15-2-140-146

4. Nemirovsky DR, Singh R, Jalalian A, Malik RD. Urologic dermatology: a comprehensive foray into the noninfectious etiologies of balanitis. Int J Dermatol. 2022 Dec;61(12):1467–1478. https://doi.org/10.1111/ijd.15985

5. Edwards SK, Bunker CB, Ziller F, van der Meijden WI. 2013 European guideline for the management of balanoposthitis. Int J STD AIDS. 2014 Aug;25(9):615–626. https://doi.org/10.1177/0956462414533099

6. Hirji I, Andersson SW, Guo Z, Hammar N, Gomez-Caminero A. Incidence of genital infection among patients with type 2 diabetes in the UK General Practice Research Database. J Diabetes Complications. 2012 Nov-Dec;26(6):501–505. https://doi.org/10.1016/j.jdiacomp.2012.06.012

7. Fünfstück R, Nicolle LE, Hanefeld M, Naber KG. Urinary tract infection in patients with diabetes mellitus. Clin Nephrol. 2012 Jan;77(1):40–48. https://doi.org/10.5414/cn107216

8. Petrov VI, Vinarov AZ, Vekilyan MA, Kulchenko NG. Changes in the structure of pathogens of calculous pyelonephritis complicated with diabetes mellitus type ii, in the hospital urology of the city of Volgograd. Urologiia. 2016;4:58–62. (In Russ.).

9. Slesarevskaya MN, Kuzmin IV, Kraeva LA. Candidal balanoposthitis in type 2 diabetic patients: symptoms, clinical event and treatment. Experimental and Clinical Urology. 2022;15(1):170–176. (In Russ.). https://doi.org/10.29188/2222-8543-2022-15-1-170-176

10. Morris BJ, Waskett JH, Banerjee J, Wamai RG, Tobian AA, Gray RH, et al. A 'snip' in time: what is the best age to circumcise? BMC Pediatr. 2012 Feb 28;12:20. https://doi.org/10.1186/1471-2431-12-20

11. Gromov AI, Buylov VM. Radiation diagnostics and therapy in urology. Мoscow: “GEOTAR-Media” Publ.; 2011. (In Russ.)

12. Morgunov LYu. Therapy of type 2 diabetes mellitus in elderly patients: risks and prospects. Research'n Practical Medicine Journal. 2017;4(4):110–124. (In Russ.). https://doi.org/10.17709/2409-2231-2017-4-4-12

13. Lin X, Xu Y, Pan X, Xu J, Ding Y, Sun X, et al. Global, regional, and national burden and trend of diabetes in 195 countries and territories: an analysis from 1990 to 2025. Sci Rep. 2020 Sep 8;10(1):14790. https://doi.org/10.1038/s41598-020-71908-9

14. Kulchenko NG, Vekilian MA. Data of change of microflora antibacterial sensitivity to antibiotics in patients with chronic calculous pyelonephritis and diabetes mellitus of type 2. Bulletin of the Medical Institute "REAVIZ" (Rehabilitation, Doctor and Health). 2016;3(23):85–90. (In Russ.).

15. Drivsholm T, de Fine Olivarius N, Nielsen AB, Siersma V. Symptoms, signs and complications in newly diagnosed type 2 diabetic patients, and their relationship to glycaemia, blood pressure and weight. Diabetologia. 2005 Feb;48(2):210–214. https://doi.org/10.1007/s00125-004-1625-y

16. Kalra S, Chawla A. Diabetes and balanoposthitis. J Pak Med Assoc. 2016 Aug;66(8):1039–1041.

17. Kaprin AD, Kostin AA, Kulchenko NG, Kruglov DP, Mangutov FSh, Matsey AI. Diagnosis of vasculogenic erectile dysfunction. What's new? Bulletin of the Medical Institute "REAVIZ" (Rehabilitation, Doctor and Health). 2016;4(24):73–78. (In Russ.).

18. Kaprin AD, Kostin AA, Kul'chenko NG, Fomin DK, Popov SV, Kruglov DP., Mangutov F.Sh.. Diagnostic capabilities of penile scintigraphy in patients with vasculogenic erectile dysfunction. Experimental and Clinical Urology. 2017;(1):68–72. (In Russ.).

19. Kawai T, Autieri MV, Scalia R. Adipose tissue inflammation and metabolic dysfunction in obesity. Am J Physiol Cell Physiol. 2021 Mar 1;320(3):C375–C391. https://doi.org/10.1152/ajpcell.00379.2020

20. Zhang YX, Ou MY, Yang ZH, Sun Y, Li QF, Zhou SB. Adipose tissue aging is regulated by an altered immune system. Front Immunol. 2023 Feb 17;14:1125395. https://doi.org/10.3389/fimmu.2023.1125395